About
Christian Sell, PhD, is a professor in the Department of Biochemistry & Molecular Biology at Drexel University College of Medicine, where his research focuses on aging biology, neuroendocrine networks, mTOR signaling, and rapamycin-based interventions. He is also a co-founder and Chief Scientific Officer of Hayflick Therapeutics, a development-stage biotech company advancing topical rapamycin for cellular aging applications. Public sources position him as a scientific and translational-aging leader rather than an investor or fund manager.
Areas of interest
longevitybiotechaging biologygerosciencemTORrapamycincellular senescencedermatologyneuroendocrine networks